To, Daphne
Wong, Jenna C.
Laur, Celia
Oliva, Laura
Ladak, Zeenat
Passalent, Laura
Thorne, J. Carter
Widdifield, Jessica
King, Lauren K.
Article History
Received: 10 January 2026
Accepted: 11 August 2026
First Online: 14 August 2026
Declarations
Ethics approval and consent to participate: This study was approved by the University of Toronto Health Sciences Research Ethics Board (#47143). Written informed consent was obtained from participants during the original study (#45644). The study was conducted in accordance with the criteria of the Declaration of Helsinki.
Consent for publication: Not applicable.
Competing interests: J. Carter Thorne is the founder of the Center of Arthritis Research Excellence (CArE) but was not involved in data collection or analysis. Laura Passalent is Program Co-Director of the Advanced Clinician Practitioner in Arthritis Care Program (ACPAC), has received honoraria from AbbVie Canada and Novartis; has received funding for research from UCB Pharmaceuticals and acts as a consultant for UCB Pharmaceuticals. Daphne To is an ACPAC trainee.